What's new

Human medicines European public assessment report (EPAR): Obodence, denosumab, Date of authorisation: 12/02/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Obodence, denosumab, Date of authorisation: 12/02/2025, Revision: 1, Status: Authorised

May 6, 2025 - 14:21
 0
Human medicines European public assessment report (EPAR): Obodence, denosumab, Date of authorisation: 12/02/2025, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Obodence, denosumab, Date of authorisation: 12/02/2025, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

Hyatt Regency Aruba Resort Spa & Casino Unveils Transformative Renovation

Next Article

Texas renewables restrictions could increase power prices by 14% in 2035: Aurora

Related Posts

Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutinib, Date of authorisation: 30/10/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0

Human medicines European public assessment report (EPAR): Hympavzi, marstacimab, Date of authorisation: 18/11/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 28, 2025  0

List of eligible industry stakeholder organisations

Apr 29, 2025  0